Reply to: The potential and challenges of radiomics in uncovering prognostic and molecular differences in interstitial lung disease associated with systemic sclerosis

Eur Respir J. 2022 Jun 16;59(6):2200303. doi: 10.1183/13993003.00303-2022. Print 2022 Jun.

Janine Schniering^{1

2}, Malgorzata Maciukiewicz^{1

3}, Stephanie Tanadini-Lang⁴, Britta Maurer^{5

3}

¹ Center of Experimental Rheumatology, Dept of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
² Institute of Lung Biology and Disease and Comprehensive Pneumology Center, Helmholtz Zentrum München, Member of the German Center for Lung Research (DZL), Munich, Germany.
³ Dept of Rheumatology and Immunology, University Hospital Bern, University Bern, Bern, Switzerland.
⁴ Dept of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
⁵ Center of Experimental Rheumatology, Dept of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland [email protected].

No abstract available

Publication types